Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial

• SARRIS AH

Journal

• Oncology

  Oncology 16 27-31, 2002

Details

• CRID: 1573387450206690048
• NII Article ID: 10018767765
• Data Source:
  • CiNii Articles